Medicines for Europe

Medicines for Europe represents the generic, biosimilar and value-added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members directly employ 190,000 people at over 400 manufacturing and 126 R&D sites in Europe and invest up to 17% of their turnover in R&D investment. Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines,...

Generic medicines,pharmaceuticals,biosimilar medicines,public health,value added medicines,regulatory affairs,legal and ip affairs,market access,and access to medicines

Medicines for europe operates in the Pharmaceutical manufacturing industry.

Medicines for europe's revenue is 11m - 100m

Medicines for europe has 51 - 200 employees.